12:00 AM
 | 
Jul 14, 2008
 |  BioCentury  |  Product Development

Weighing in

Weighing in

Company Product [current status] Study details Mean weight reduction
Abbott (NYSE:ABT) Meridia sibutramine [Mkt] 1 trial in 733 pts, 6 mos 6.6-13.6 lbs (5-20 mg doses) vs. 2 lbs for placebo
1 trial in 463 pts, 1 yr 9.8 and 14 lbs (10 and 15 mg) vs. 3.5 lbs for placebo
Roche (SWX:ROG) Xenical orlistat [Mkt] 5 trials in 2,680 pts; 26 wks 12.4 lbs vs. 6.2 lbs for placebo
5 trials in 2,680 pts; 52 wks 13.4...

Read the full 588 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >